NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/09/2025
Voltar para busca
Dado oficial do USPTO
ORA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5
Data de depósito
20/04/2023
Data de registro
16/09/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/09/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
19/06/2023
Primeiro uso no comércio
19/10/2024
Código do desenho
5
Tipo de titular
03
Localização do titular
Zhubei, Hsinchu County, TW
Examinador
YOUNG, THOMAS PAUL
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word, "ora", in a stylized font.
Titulares e representantes
Titulares
Inti Taiwan, Inc.
Representantes
Chinhwei Chen Jianq Chyun Intellectual Property Office
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Bacterial preparations other than for medical and veterinary use; Chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; Industrial chemicals; Biological preparations for use in industry and sciencenot for medical or veterinary purposes; Chemical preparations for scientific purposesother than for medical or veterinary use; Cultures of microorganismsother than for medical and veterinary use; Chemicals for use in science; Nucleic acid amplification reagents for scientific and research usenot for medical use; Reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) for scientific and research usenot for medical or veterinary purposes; Chemical reagents for genetic identity testingnot for medical purposes; Chemical reagents for use in diagnostic testsother than for medical or veterinary use; Chemical reagents for use in analytical testsother than for medical or veterinary use; Chemical reagents for non-medical purposes; Enzymes for detecting proteins for scientific purposesother than for medical use; Biochemical testing reagents other than for medical purposes; Chemical reagents for laboratory useother than for medical or veterinary use; Chemical reagents for use in genetic research; Chemical reagents for genetic identity testingfor research purposes; Testing reagents for scientific use; Kits comprising chemicals for use in industry for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicatingsequencing and for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids and biological and biochemical sample materialindustrial chemicals for reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplificationsequencing and analysisnot for medical purposes; Clinical diagnostic reagents for scientific or research use; Diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiologyfor scientific use; Chemicalbiochemical and biotechnological products for commercial and scientific usebuffer solutionsnucleic acidsnucleic acid derivatives and proteins for chemical analysisnot for medical or veterinary purposes
Classe 5
Enzyme preparations for medical purposes; Bacterial preparations for medical purposes; Medical diagnostic assays for testing of bodily fluids and tissue in the detectionmonitoringprediction of disease or other conditionsdisease stateshormone leveldrug leveldrug responseorgan function effectivenessclinical response; Reagents for use in diagnostic tests for medical purposes; Diagnostic biomarker reagents for medical purposes; Reagent paper for medical purposes; Clinical diagnostic reagents for medical use; Chemical test reagents for medical use; Chemical reagentsdiagnostic medical reagent strips for use by individuals to test their own body fluids and for use by the medical profession; Reagents for use in medical genetic testing; Genetic identity tests comprised of reagents for medical purposes; Medical diagnostic reagents and assays for testing of body fluids; Nucleic acid sequences and chemical reagents for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
16/09/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/09/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
28/08/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/08/2025
IUAF
USE AMENDMENT FILED
19/02/2025
EISU
TEAS STATEMENT OF USE RECEIVED
19/02/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2024
PUBO
PUBLISHED FOR OPPOSITION
09/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/06/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
08/05/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/05/2024
DRRR
DIVISIONAL REQUEST RECEIVED
11/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
11/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/01/2024
GNRT
NON-FINAL ACTION E-MAILED
18/01/2024
CNRT
NON-FINAL ACTION WRITTEN
18/01/2024
DOCK
ASSIGNED TO EXAMINER
18/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/05/2023
NWAP
NEW APPLICATION ENTERED
24/04/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ORA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.